Expert consensus on the clinical application of ormutivimab injection for use against the rabies virus.

Background: There are no local or international guidelines or consensus on the use of mAbs against the rabies virus.

Research Design And Methods: An expert group in the field of rabies prevention and control formulated the consensus presented in this paper.

Results: Class III exposed persons to rabies for the first time; Identify type II exposed persons with immune deficiency; those who are first exposed to Class II and re-exposed to Class III within 7 days.